EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism

Amar Chandra Mahatha, Octavio Ramos-Espinosa, Dhemerson Souza de Lima, Ethan Y Liu, Sarah Vaidyan, Jianguo Liu

BIO-PROTOCOL · 2026 · 16 (1395)

DOI: 10.21769/bioprotoc.5660 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift BIO-PROTOCOL, 2026. Verfasst von Amar Chandra Mahatha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO,…. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We established a step-by-step approach for generating a single-nucleotide mutation in the promoter region of an immune regulatory gene in human monocyte THP-1 cells by employing a plasmid-based CRISPR-Cas9 system delivered via transfection with a homology-directed repair template DNA (HDR). Key steps include designing a single-guide RNA (sgRNA), cloning it into a CRISPR plasmid encoding the Cas9 protein, transfection of the plasmid constructs along with single-stranded oligonucleotide repair template (ssODNs) into THP-1 cells, followed by selection and validation. This approach provides a precise and relevant model to investigate the role of single polymorphisms in the regulation of inflammatory gene expression in human monocytes. In addition to the rs1024611 single-nucleotide polymorphism (SNP), this CRISPR/Cas9-based strategy is broadly applicable to functional studies of noncoding and coding variants in innate immune genes. Key features • Precise genome editing: CRISPR-Cas9-mediated editing of the rs1024611 SNP in the endogenous CCL2 promoter in THP-1 cells using a single-stranded donor oligonucleotide. • Generate THP-1 monocytic cell lines: Differing only at the rs1024611 locus, allowing precise comparison of allele-specific effects on the same genetic background. • The protocol includes strategies for single-cell cloning, PCR-based genotyping, and Sanger sequencing to confirm precise genome editing. • While this study focuses on the CCL2-2518 SNP, it provides a framework for future investigations of other noncoding variants or regulatory SNPs in immune-related genes.

Schlagwörter

Stichwörter der Autor:innen

CRISPR-Cas9Single-cell clonal isolationSingle-nucleotide polymorphismTHP-1 cellsrs1024611 SNP

Autor:innen und Institutionen

  • Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA.
  • College of Arts and Sciences; Saint Louis University, Saint Louis, MO, USA.
  • Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, MO, USA.

Zitieren

APA

Mahatha, A. C., Ramos-Espinosa, O., de Lima, D. S., Liu, E. Y., Vaidyan, S., & Liu, J. (2026). Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism. BIO-PROTOCOL, 16(1395). https://doi.org/10.21769/bioprotoc.5660

Vancouver

Mahatha AC, Ramos-Espinosa O, de Lima DS, Liu EY, Vaidyan S, Liu J. Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism. BIO-PROTOCOL. 2026;16(1395). doi:10.21769/bioprotoc.5660

BibTeX
@article{Mahatha2026,
  author = {Mahatha, Amar Chandra and Ramos-Espinosa, Octavio and de Lima, Dhemerson Souza and Liu, Ethan Y and Vaidyan, Sarah and Liu, Jianguo},
  title = {Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism},
  journal = {BIO-PROTOCOL},
  year = {2026},
  volume = {16},
  number = {1395},
  doi = {10.21769/bioprotoc.5660}
}
Kostenlos starten →